Massive study tracks 4,000 Kids' implants for safety
NCT ID NCT05361980
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 4,000 children who receive orthopedic implants (like rods or screws) during standard care for bone fractures, deformities, or hip problems. Researchers will track how long the implants last, any complications, and how well they work over time. The goal is to gather real-world data to ensure these devices are safe and effective for kids.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pediatric orthopaedic implant
- What this could lead to
- If successful, this registry will provide crucial data on how well these implants work and how safe they are over time, helping guide future treatment decisions.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data but does not test a new intervention, so it won't directly improve outcomes for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 4,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2022
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Anyone who meets the eligibility criteria and is within the age limits listed in the above sections can participate in this study.
- Ages
-
0 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly * Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product * Informed consent/assent is required Exclusion Criteria: * Patients with a demonstrated sensitivity to metals * Patients with an inability to follow a post-operative regimen
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Deformity of limb are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
BC Children's Hospital
RECRUITINGVancouver, British Columbia, V6H 3N1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hip surgery pain targeted with nerve block in new trial
- Could bunion surgery patients walk right away? trial puts it to the test
- Sensor-Aided rehab could transform knee replacement recovery
- Can a new knee implant design offer better Long-Term relief?
- Could outdoor play in kindergarten improve Kids' mental and physical health?
- Can a new combo drug tame childhood leukemia that Won't quit?